Clinical Trial Update: Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp [Phase 2, Phase 3]

View source ↗

Summary

Moberg Pharma AB completed Phase 2 and Phase 3 trials evaluating two topical K40 formulations for seborrhoeic dermatitis of the scalp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seborrhoeic Dermatitis of the Scalp

Drugs mentioned

• K40 topical formulation A
• K40 topical formulation B

Snippet

Sponsor: Moberg Pharma AB | Conditions: Seborrhoeic Dermatitis of the Scalp | Phase 2, Phase 3 | Status: COMPLETED